We are live on ! Find out more
SQZ

SQZ Biotechnologies Company

Delisted

SQZ was delisted on the 3rd of July, 2023.

49 hedge funds and large institutions have $159M invested in SQZ Biotechnologies Company in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 7

28% more capital invested

Capital invested by funds: $125M → $159M (+$34.7M)

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

4% more funds holding

Funds holding: 4749 (+2)

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
26
Reduced
7
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$454K +$306K +23,428 +294%
JF
27
Jump Financial
Illinois
$389K +$352K +26,955 New
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$373K +$338K +25,836 New
CSS
29
Cubist Systematic Strategies
Connecticut
$325K +$294K +22,524 New
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$282K +$204K +15,639 +401%
RAM
31
Redmond Asset Management
Virginia
$238K
TRCT
32
Tower Research Capital (TRC)
New York
$228K +$180K +13,815 +687%
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$201K +$182K +13,907 New
EMG
34
ETF Managers Group
New Jersey
$114K -$4.02K -308 -4%
ACM
35
ACT Capital Management
Pennsylvania
$109K +$98K +7,500 New
BAM
36
Baldrige Asset Management
Pennsylvania
$79K +$71.2K +5,447 New
UBS Group
37
UBS Group
Switzerland
$54K +$30.2K +2,314 +159%
Wells Fargo
38
Wells Fargo
California
$51K -$8.22K -629 -15%
AIG
39
American International Group
New York
$36.6K +$127K +9,743 +0.4%
Legal & General Group
40
Legal & General Group
United Kingdom
$26K +$18K +1,378 +314%
AIP
41
Ameritas Investment Partners
Nebraska
$26K +$18.4K +1,412 +379%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$23K +$11.3K +863 +124%
Citigroup
43
Citigroup
New York
$16K +$9.56K +732 +209%
SO
44
STRS Ohio
Ohio
$15K
HI
45
Hudock Inc
Pennsylvania
$7K -$810 -62 -10%
Rockefeller Capital Management
46
Rockefeller Capital Management
New York
$5K +$5.09K +390 New
FDCDDQ
47
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.52K
PA
48
Parallel Advisors
California
$1K +$967 +74 New
BM
49
Bridger Management
New York
-$9.96M -807,827 Closed
CCM
50
CAAS Capital Management
New York
-$1.8M -131,849 Closed

SQZ Hedge Fund Activity: Q2 2021 in Review

49 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q2 2021, worth a combined $159M — up 28% from $125M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SQZ positions and 9 closed out — a net gain of 2 holders — while 26 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $12.9M. The largest seller was Bridger Management, exiting entirely with an estimated $9.96M sold.

  • 49 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q2 2021, up from 47 in Q1 2021.
  • Funds reported $159M of SQZ Biotechnologies Company stock for Q2 2021, up 28% quarter-over-quarter.
  • 11 funds opened new SQZ Biotechnologies Company positions in Q2 2021 and 9 closed out, a net change of +2 holders.
  • The largest SQZ Biotechnologies Company buyer in Q2 2021 was BlackRock, an estimated $12.9M added.
  • The largest SQZ Biotechnologies Company seller in Q2 2021 was Bridger Management, an estimated $9.96M sold.

Based on aggregated 13F filings for Q2 2021.